Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.
Freise
C E
CE
Department of Surgery, University of California, San Francisco 94143.
Rowley
H
H
Lake
J
J
Hebert
M
M
Ascher
N L
NL
Roberts
J P
JP
D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006429:Hemiplegia / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
D016572:Cyclosporine; D011239:Prednisolone; D016559:Tacrolimus; D008775:Methylprednisolone